Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 756 of 1,261

  1. US 9017743

    Bacterial extract for digestive or urinary tract disorders and process for its preparation

    OM PHARMA · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  2. US 9018238

    Inhibitor of casein kinase 1δ and casein kinase 1ε

    Pharmadesign, Inc. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  3. US 9017725

    Topical drug delivery systems for ophthalmic use

    AURINIA PHARMACEUTICALS INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  4. US 9017670

    Anti-Tie2 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  5. US 9017653

    Nitric oxide-releasing compositions and methods

    The Board of Regents of the University of Texas System · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  6. US 9017661

    Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes

    The Board of Regents of the University of Texas System · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  7. US 2015112285

    Transdermal Therapeutic System For Administering Rivastigmine Or Derivatives Thereof

    ACINO AG [DE] · Granted Apr 23, 2015 · Expires Apr 18, 2035

    granted

  8. US 9012467

    Compositions for intratumoral administration

    Covidien LP · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  9. US 9012647

    Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  10. US 9012618

    Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  11. US 9011844

    Human cystathionine β-synthase variants and methods of production thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  12. US 9011857

    Methods of treating cancer by administering EMP2 antibodies

    The Regents of the University of California · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  13. US 9011913

    Use of functionalized magnetic nanoparticles in cancer detection and treatment

    The Regents of the University of California · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  14. US 9012447

    5-HT3 receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  15. US 9012223

    Methods for enhancing genome stability and telomere elongation in embryonic stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  16. US 9012624

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Alnylam Pharmaceuticals, Inc. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  17. US 9012641

    Crystalline forms of Prasugrel salts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  18. US 9012498

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  19. US 9012508

    Administration of intravenous ibuprofen

    Cumberland Pharmaceuticals Inc. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  20. US 9012469

    Crystalline naloxol-peg conjugate

    Nektar Therapeutics · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  21. US 9012485

    Dual-acting imidazole antihypertensive agents

    Theravance Biopharma R&D IP, LLC · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  22. US 9012496

    Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  23. US 9012473

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  24. US 9012460

    1-(2-phenoxymethylphenyl)piperazine compounds

    Theravance Biopharma R&D IP, LLC · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.